While HPLC and mass spec make inroads into nontraditional markets, interest remains in molecular techniques that address the unique needs of clinicians and drug developers.
A new catalyst combining copper nanoparticles with a special type of graphene could lead to a greener way of producing ethylene, a key commodity chemical